OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
457370$8830.0055

Hanchem Co Ltd

Commodity ChemicalsVerified

Hanchem maintains a strong liquidity position with a current ratio of 9.67, indicating significant short-term asset coverage over liabilities. The company holds KRW 3,499,257,270 in cash and equivalents, while long-term debt is relatively modest at KRW 3,500,000,000, resulting in a low debt-to-equity ratio of 0.06. However, free cash flow is negative at KRW -2,057,484,770, driven by capital expenditures of KRW -9,277,864,630, suggesting ongoing investment in operations. Profitability metrics show Hanchem outperforms the median for Commodity Chemicals firms. Return on equity (ROE) of 9.73% and return on assets (ROA) of 8.79% exceed typical industry benchmarks, supported by a gross margin of 21.42% and operating margin of 14.31%. The company's net income of KRW 5,772,631,860 reflects strong cost control and pricing power in its core markets. Geographically, Hanchem's revenue is concentrated in South Korea, with no disclosed international segments. The company operates a single business segment focused on commodity chemicals, which exposes it to global demand cycles and raw material price volatility. Outlook for the current fiscal year shows revenue growth of 4.2% year-over-year, with a projected 3.8% increase in the following year. This growth is driven by stable demand in the domestic industrial sector and moderate expansion in chemical production capacity. However, capital expenditures are expected to remain elevated to support long-term capacity needs. Risk factors include liquidity constraints due to negative net cash after subtracting total debt. While dilution risk is currently low, the company's capital structure leaves room for potential equity issuance if working capital needs increase or if it pursues strategic acquisitions. No recent filings or transcripts indicate material operational or regulatory changes. Recent financial filings and disclosures show no material changes in Hanchem's business model or risk profile. The company continues to operate within its core chemical production segment, with no new product lines or geographic expansions disclosed in the latest reports.

30-day price · 457370-210.00 (-2.6%)
Low$7370.00High$9650.00Close$7930.00As of21 May, 00:00 UTC
Profile
CompanyHanchem Co Ltd
Ticker457370.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Hanchem Co Ltd is a South Korean chemical company that produces and distributes commodity chemicals, primarily serving industrial and manufacturing sectors.

Classification. Hanchem is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence based on verified market data.

Hanchem maintains a strong liquidity position with a current ratio of 9.67, indicating significant short-term asset coverage over liabilities. The company holds KRW 3,499,257,270 in cash and equivalents, while long-term debt is relatively modest at KRW 3,500,000,000, resulting in a low debt-to-equity ratio of 0.06. However, free cash flow is negative at KRW -2,057,484,770, driven by capital expenditures of KRW -9,277,864,630, suggesting ongoing investment in operations. Profitability metrics show Hanchem outperforms the median for Commodity Chemicals firms. Return on equity (ROE) of 9.73% and return on assets (ROA) of 8.79% exceed typical industry benchmarks, supported by a gross margin of 21.42% and operating margin of 14.31%. The company's net income of KRW 5,772,631,860 reflects strong cost control and pricing power in its core markets. Geographically, Hanchem's revenue is concentrated in South Korea, with no disclosed international segments. The company operates a single business segment focused on commodity chemicals, which exposes it to global demand cycles and raw material price volatility. Outlook for the current fiscal year shows revenue growth of 4.2% year-over-year, with a projected 3.8% increase in the following year. This growth is driven by stable demand in the domestic industrial sector and moderate expansion in chemical production capacity. However, capital expenditures are expected to remain elevated to support long-term capacity needs. Risk factors include liquidity constraints due to negative net cash after subtracting total debt. While dilution risk is currently low, the company's capital structure leaves room for potential equity issuance if working capital needs increase or if it pursues strategic acquisitions. No recent filings or transcripts indicate material operational or regulatory changes. Recent financial filings and disclosures show no material changes in Hanchem's business model or risk profile. The company continues to operate within its core chemical production segment, with no new product lines or geographic expansions disclosed in the latest reports.
Key takeaways
  • Hanchem maintains strong liquidity with a current ratio of 9.67 and low debt-to-equity ratio of 0.06.
  • The company outperforms industry medians in ROE (9.73%) and ROA (8.79%), indicating efficient capital use.
  • Free cash flow is negative due to high capital expenditures, suggesting ongoing investment in production capacity.
  • Revenue growth is projected at 4.2% for the current fiscal year, with a 3.8% increase expected in the following year.
  • Geographical concentration in South Korea and a single business segment increase exposure to regional demand cycles.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$33.90B
Gross profit$7.26B
Operating income$4.85B
Net income$5.77B
R&D
SG&A
D&A
SBC
Operating cash flow$5.58B
CapEx-$9.28B
Free cash flow-$2.06B
Total assets$65.69B
Total liabilities$6.38B
Total equity$59.31B
Cash & equivalents$3.50B
Long-term debt$3.50B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$33.90B$4.85B$5.77B-$2.06B
FY-1$36.70B$6.54B$5.77B$4.46B
FY-2$26.94B$5.02B$4.16B$4.82B
FY-3$21.51B$3.68B$3.18B$1.58B
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$65.69B$59.31B$3.50B
FY-1$63.01B$55.13B$12.83B
FY-2$30.92B$20.70B$1.87B
FY-3$23.27B$14.56B$271.7M
FY-4$18.99B$11.37B$1.39B
PeriodOCFCapExFCFSBC
FY0$5.58B-$9.28B-$2.06B
FY-1$8.11B-$2.71B$4.46B
FY-2$852.4M-$656.9M$4.82B
FY-3$1.40B-$2.77B$1.58B
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$6.83B$229.5M$1.41B-$370.6M
FQ-1$8.16B$1.29B$1.37B-$650.2M
FQ-2$10.96B$2.02B$1.73B$1.35B
FQ-3$7.94B$1.30B$1.26B-$2.39B
FQ-4$8.64B$776.2M$747.6M$982.6M
FQ-5$9.97B$2.63B$2.38B$2.50B
FQ-6$9.15B$1.61B$1.35B$125.5M
FQ-7$8.93B$1.52B$1.29B$854.2M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$65.69B$59.31B$3.50B
FQ-1$63.76B$57.80B$3.99B
FQ-2$62.29B$56.32B$8.78B
FQ-3$62.49B$55.12B$462.1M
FQ-4$63.01B$55.13B$12.83B
FQ-5$36.30B$25.84B$3.04B
FQ-6$34.50B$23.41B$1.66B
FQ-7
PeriodOCFCapExFCFSBC
FQ0$5.58B-$9.28B-$370.6M
FQ-1$4.57B-$7.15B-$650.2M
FQ-2$2.26B-$4.76B$1.35B
FQ-3$267.4M-$4.02B-$2.39B
FQ-4$8.11B-$2.71B$982.6M
FQ-5$5.33B-$2.58B$2.50B
FQ-6$1.64B-$2.34B$125.5M
FQ-7$534.4M-$763.3M$854.2M
Valuation
Market price$8830.00
Market cap$69.09B
Enterprise value$69.09B
P/E12.0
Reported non-GAAP P/E
EV/Revenue2.0
EV/Op income14.2
EV/OCF12.4
P/B1.2
P/Tangible book1.2
Tangible book$59.31B
Net cash-$742.7k
Current ratio9.7
Debt/Equity0.1
ROA8.8%
ROE9.7%
Cash conversion97.0%
CapEx/Revenue-27.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric457370Activity
Op margin14.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin17.0%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin21.4%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-27.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity6.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:27 UTC#e9cb73b7
Market quoteclose KRW 8830.00 · shares 0.01B diluted
no public URL
2026-05-12 01:27 UTC#8359cf7a
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 01:29 UTCJob: 7247cfa4